Brentuximab vedotin plus bendamustine is an effective salvage regimen for pediatric patients with relapsed Hodgkin lymphoma Meeting Abstract


Authors: Gulati, N.; Boulad, F.; Cancio, M. I.; Curran, K. J.; Jackson, C.; Kernan, N.; Kung, A. L.; O'Reilly, R.; Prockop, S.; Ramaswamy, K.; Scaradavou, A.; Spitzer, B.; Shukla, N.; Steinherz, P. G.; Forlenza, C.
Abstract Title: Brentuximab vedotin plus bendamustine is an effective salvage regimen for pediatric patients with relapsed Hodgkin lymphoma
Meeting Title: 59th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 130
Issue: Suppl. 1
Meeting Dates: 2017 Dec 9-12
Meeting Location: Atlanta, GA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2017-12-07
Language: English
ACCESSION: WOS:000432419705349
PROVIDER: wos
DOI: 10.1182/blood.V130.Suppl_1.5172.5172
Notes: Meeting Abstract: 5172 -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Nancy Kernan
    505 Kernan
  2. Farid Boulad
    326 Boulad
  3. Susan E Prockop
    259 Prockop
  4. Kevin Joseph Curran
    127 Curran
  5. Peter G Steinherz
    219 Steinherz
  6. Richard O'Reilly
    735 O'Reilly
  7. Neerav Shukla
    140 Shukla
  8. Barbara Spitzer
    72 Spitzer
  9. Carolyn Chang Jackson
    11 Jackson
  10. Maria   Cancio
    45 Cancio
  11. Andrew L Kung
    84 Kung
  12. Nitya Gulati
    4 Gulati